Palantir Technologies Stock Could Reach $300 by the End of 2028

Palantir shares have risen 70% since the beginning of August to just over $200. The article argues the stock could exceed $300 by the end of 2028, citing $13.1 billion in remaining deal value at the end of Q2, up 83% year over year, and $3.37 billion in new Q2 contracts versus $1.93 billion in quarterly revenue. Analysts expect 2026 EPS of $1.62, up 116%; the $300 scenario assumes EPS doubles in both 2027 and 2028 to $6.48 and the stock trades at 46 times earnings.

Analysis

The bullish case hinges less on AI-software growth than on Palantir converting contracted value into recognized revenue and earnings at unusually high incremental margins. The article’s bridge to its share-price outcome assumes earnings double in each of two consecutive years after 2026; that is a scenario, not evidence supplied by the contract figures. Remaining deal value and quarterly contract awards are not equivalent to near-term revenue: duration, cancellation or opt-out terms, deployment capacity, and conversion timing matter. Verify these in filings and guidance before underwriting the acceleration.

The market mechanism cuts both ways. Successful customer deployments could expand usage and margins, but broad AI budgets do not guarantee Palantir wins share; Microsoft, Snowflake, and other data-platform vendors can bundle competing capabilities. Productivity gains may also reduce customer labor or software budgets rather than flow directly to Palantir. With no current valuation or consensus detail independently established here, the key risk is multiple compression if growth remains strong but falls short of the implied exceptional path.

Near term, momentum may persist, but the 1–3 month test is reported revenue conversion, customer expansion, and forward guidance—not headline contract value. Over 6–18 months, watch whether margins rise alongside commercial growth and whether contract commitments convert on schedule. The thesis weakens materially with slowing customer growth, weaker guidance, or deal-value growth that fails to translate into revenue and cash generation.

Key Decisions for Investors

• Do not chase the rally on the article’s price scenario alone. Treat the assumed earnings trajectory as an upside case, not a base case, until management guidance and reported results support it.
• Set a catalyst watch for the next earnings reports: compare revenue growth and commercial customer expansion with remaining deal value, and track margin and cash-flow conversion. If contract metrics accelerate without corresponding revenue conversion, reduce exposure rather than extrapolating bookings.
• For investors seeking upside, consider a staged position only after results confirm accelerating revenue and margins; size against the possibility that a high-growth company can still de-rate on an earnings miss. Current share price, valuation basis, and options pricing are not supplied, so no entry level or options structure is justified here.
• If growth or guidance disappoints while the valuation remains dependent on rapid earnings compounding, consider a defined-risk put spread as a hedge, subject to checking live valuation, option liquidity, and premium. The bearish thesis is falsified by sustained revenue conversion, margin expansion, and guidance that validates the assumed earnings acceleration.